Disparity in the use of Alzheimer's disease treatment in Southern Brazil

Alzheimer's disease (AD) treatment is freely available in the Brazilian public health system. However, the prescription pattern and its associated factors have been poorly studied in our country. We reviewed all granted requests for AD treatment in the public health system in October 2021 in th...

Descripción completa

Detalles Bibliográficos
Autores principales: De Marco, Maisa, Brandi, Ana Laura, Bieger, Andrei, Krug, Bárbara, Camozzato, Analuiza, Picon, Paulo D., Chaves, Marcia Lorena Fagundes, Castilhos, Raphael Machado
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10261112/
https://www.ncbi.nlm.nih.gov/pubmed/37308535
http://dx.doi.org/10.1038/s41598-023-36604-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10261112/
https://www.ncbi.nlm.nih.gov/pubmed/37308535
http://dx.doi.org/10.1038/s41598-023-36604-4

Ejemplares similares